TARDBP and frontotemporal dementia: In addition, MAP6 has been found to impact dendritic lysosome transport and trafficking, which can be impaired by the expression of an FTD risk factor with TDP-43 pathology (Kim et al., 2010; Schwenk et al., 2014).